Abstract:At present, COVID-19 poses a serious threat to global human health, and the cumulative confirmed cases in America, Brazil and India continue to grow rapidly. Therefore, the prediction models of cumulative confirmed cases in America, Brazil and India from August 1, 2021 to December 31, 2021 were established. In this study, the prevalence data of COVID-19 from 1 August 2021 to 31 December 2021 were collected from the World Health Organization website. Several ARIMA models were formulated with different ARIMA parameters. ARIMA (7,2,0), ARIMA (3,2,1), and ARIMA (10,2,4) models were selected as the best models for America, Brazil, and India, respectively. Initial combinations of model parameters were selected using the automated ARIMA model, and the optimized model parameters were then found based on Bayesian information criterion (BIC). The analytical tools autocorrelation function (ACF), and partial autocorrelation function (PACF) were used to evaluate the reliability of the model. The performance of different models in predicting confirmed cases from January 1, 2022 to January 5, 2022 was compared by using root mean square error (RMSE), mean absolute error (MAE), and mean absolute percentage error (MAPE). This study shows that ARIMA models are suitable for predicting the prevalence of COVID-19 in the future. The results of the analysis can shed light on understanding the trends of the outbreak and give an idea of the epidemiological stage of these regions. Besides, the prediction of COVID-19 prevalence trends of America, Brazil, and India can help take precautions and policy formulation for this epidemic in other countries. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement The study was fully funded by National Major Science and Technology of China (2018ZX107130003) and The National Natural Science Foundation of China (12031010). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes According to the reasonable requirements of the author, all the data generated in this study can be obtained. All the data generated in the current work are included in the manuscript, and all the data generated can be consulted online. <https://www.who.int/emergencies/disease-outbreak-news>

A Comprehensive Statistical Analysis of COVID-19 Trends: Global and U.S. Insights through ARIMA, Regression, and Spatial Models

Analysis of the Spread of COVID-19 in the USA with a Spatio-Temporal Multivariate Time Series Model

Trend Analysis and Intervention Effect Starting Point Detection of COVID-19 Epidemics Using Recalibrated Time Series Models — Worldwide, 2020

Prediction and analysis of COVID-19 daily new cases and cumulative cases: times series forecasting and machine learning models

Predicting the Pandemic COVID-19 Using ARIMA Model

Prediction of COVID-19 Data Using Hybrid Modeling Approaches

Enhancing COVID-19 Case Forecasting in the United States: A Comparative Analysis of ARIMA, SARIMA, and RNN Models with Grid Search Optimization

A COVID-19 Pandemic Artificial Intelligence–Based System With Deep Learning Forecasting and Automatic Statistical Data Acquisition: Development and Implementation Study

Predictive and analysis of COVID-19 cases cumulative total: ARIMA model based on machine learning

Time Series Forecasting of US COVID-19 Transmission

Empirical Quantitative Analysis of COVID-19 Forecasting Models

Integrating County-Level Socioeconomic Data for COVID-19 Forecasting in the United States

Adaptive Multi-Factor Quantitative Analysis and Prediction Models: Vaccination, Virus Mutation and Social Isolation on COVID-19

Statistical Machine Learning Meets High-Dimensional Spatiotemporal Challenges -- A Case Study of COVID-19 Modeling

Prediction of global omicron pandemic using ARIMA, MLR, and Prophet models

Data-driven Analytical Models of COVID-2019 for Epidemic Prediction, Clinical Diagnosis, Policy Effectiveness and Contact Tracing: A Survey

Comparison of Predictive Models and Impact Assessment of Lockdown for COVID-19 over the United States

Analyzing the State of COVID-19: Real-time Visual Data Analysis, Short-Term Forecasting, and Risk Factor Identification

Modeling of the COVID-19 impact on air passenger traffic in the US, European countries, and China

Comparative Analysis of Machine Learning Approaches to Analyze and Predict the Covid-19 Outbreak

Quantitative Study on American COVID-19 Epidemic Predictions and Scenario Simulations